Gaur Aditya H, Liu Tiebin, Knapp Katherine M, Daw Najat C, Rao Bhaskar N, Neel Michael D, Rodriguez-Galindo Carlos, Brand Diane, Adderson Elisabeth E
Department of Infectious Diseases, St. Jude Children's Research Hospital, 332 N. Lauderdale Street, Memphis, TN 38105, USA.
Cancer. 2005 Aug 1;104(3):602-10. doi: 10.1002/cncr.21212.
The epidemiology, risk factors, and efficacy of therapy for infections complicating limb-sparing surgery (LSS) are not understood completely.
The authors conducted a retrospective review of children and adolescents with bone malignancies who underwent LSS.
One hundred three patients underwent 104 LSS procedures. Patients experienced a median of 4 infections (range, 0-13 infections), including focal bacterial infections in 67% of patients and bacteremia in 21% of patients. Infections at the LSS site occurred in 26% of patients, and 21% of patients developed orthopedic device infections (ODIs). Compared with patients without ODIs, patients who developed ODIs were more likely to be African American and to have wound infections, and they were less likely to have tumors of the femur than the tibia. In a multivariate analysis, only African-American race and local infection at the LSS site retained a significant association with ODIs. Among survivors, patients who developed ODIs were more likely to undergo amputation (odds ratio [OR], 24.0; 95% confidence interval [95%CI], 5.1-114.0; P < 0.001) and were less likely to have good functional outcomes (OR, 0.02; 95%CI, 0.002-0.15; P < 0.001) compared with patients who did not have an ODI. Overall, only 1 of 22 patients with an ODI was treated successfully without removal of the orthopedic device or amputation.
Current treatment for bone malignancies is complicated by an unexpectedly high incidence of infection. ODI was the most common reason for amputation and poor functional outcomes. The identification of risk factors for ODI may allow modifications of therapy that reduce the incidence and severity of infection, but prevention of all ODIs will require novel strategies.
保肢手术(LSS)并发感染的流行病学、危险因素及治疗效果尚未完全明确。
作者对接受LSS的儿童及青少年骨恶性肿瘤患者进行了回顾性研究。
103例患者接受了104次LSS手术。患者感染的中位数为4次(范围0 - 13次),其中67%的患者发生局灶性细菌感染,21%的患者发生菌血症。26%的患者在LSS部位发生感染,21%的患者发生骨科器械感染(ODI)。与未发生ODI的患者相比,发生ODI的患者更可能是非裔美国人且有伤口感染,且股骨肿瘤患者比胫骨肿瘤患者少。多因素分析显示,只有非裔美国人种族及LSS部位的局部感染与ODI仍存在显著关联。在幸存者中,与未发生ODI的患者相比,发生ODI的患者更可能接受截肢(比值比[OR],24.0;95%置信区间[95%CI],5.1 - 114.0;P < 0.001),且功能结局良好的可能性较小(OR,0.02;95%CI,0.002 - 0.15;P < 0.001)。总体而言,22例发生ODI的患者中只有1例在未移除骨科器械或截肢的情况下成功治愈。
目前骨恶性肿瘤的治疗因感染发生率意外高而变得复杂。ODI是截肢及功能结局不佳的最常见原因。识别ODI的危险因素可能有助于调整治疗方案以降低感染的发生率和严重程度,但预防所有ODI需要新的策略。